Skip to main content
Top
Published in: Arthritis Research & Therapy 2/2001

01-01-2001 | Commentary

The stressed synovium

Authors: Georg Schett, Makiyeh Tohidast-Akrad, Günter Steiner, Josef Smolen

Published in: Arthritis Research & Therapy | Issue 2/2001

Login to get access

Abstract

This review focuses on the mechanisms of stress response in the synovial tissue of rheumatoid arthritis. The major stress factors, such as heat stress, shear stress, proinflammatory cytokines and oxidative stress, are discussed and reviewed, focusing on their potential to induce a stress response in the synovial tissue. Several pathways of stress signalling molecules are found to be activated in the synovial membrane of rheumatoid arthritis; of these the most important examples are heat shock proteins, mitogen-activated protein kinases, stress-activated protein kinases and molecules involved in the oxidative stress pathways. The expression of these pathways in vitro and in vivo as well as the consequences of stress signalling in the rheumatoid synovium are discussed. Stress signalling is part of a cellular response to potentially harmful stimuli and thus is essentially involved in the process of synovitis. Stress signalling pathways are therefore new and promising targets of future anti-rheumatic therapies.
Literature
1.
go back to reference Hlavacek M: The role of synovial fluid filtration by cartilage in lubrication of synovial joints. IV. Squeeze-film lubrication: the central film thickness for normal and inflammatory synovial fluids for axial symmetry under high loading conditions. J Biomech. 1995, 28: 1199-1205. 10.1016/0021-9290(94)00178-7.PubMed Hlavacek M: The role of synovial fluid filtration by cartilage in lubrication of synovial joints. IV. Squeeze-film lubrication: the central film thickness for normal and inflammatory synovial fluids for axial symmetry under high loading conditions. J Biomech. 1995, 28: 1199-1205. 10.1016/0021-9290(94)00178-7.PubMed
2.
go back to reference Gomez JE, Thurston GB: Comparison of the oszillatory shear viscoelasticity and composition of pathological synovial fluids. Biorheology. 1993, 30: 409-427.PubMed Gomez JE, Thurston GB: Comparison of the oszillatory shear viscoelasticity and composition of pathological synovial fluids. Biorheology. 1993, 30: 409-427.PubMed
3.
go back to reference Shay AK, Bliven ML, Scampoli DN, Otterness IG, Milici AJ: Effects of exercise on synovium and cartilage from normal and inflamed joints. Rheumatol Int. 1995, 14: 183-189.PubMed Shay AK, Bliven ML, Scampoli DN, Otterness IG, Milici AJ: Effects of exercise on synovium and cartilage from normal and inflamed joints. Rheumatol Int. 1995, 14: 183-189.PubMed
4.
go back to reference Zou Y, Hu Y, Metzler B, Xu Q: Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells (review). Int J Mol Med. 1998, 1: 827-834.PubMed Zou Y, Hu Y, Metzler B, Xu Q: Signal transduction in arteriosclerosis: mechanical stress-activated MAP kinases in vascular smooth muscle cells (review). Int J Mol Med. 1998, 1: 827-834.PubMed
5.
go back to reference Mayr M, Li C, Zou Y, Huemer U, Hu Y, Xu Q: Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J. 2000, 14: 261-270.PubMed Mayr M, Li C, Zou Y, Huemer U, Hu Y, Xu Q: Biomechanical stress-induced apoptosis in vein grafts involves p38 mitogen-activated protein kinases. FASEB J. 2000, 14: 261-270.PubMed
6.
go back to reference Li C, Hu Y, Mayr M, Xu Q: Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways. J Biol Chem. 1999, 274: 25273-25280. 10.1074/jbc.274.36.25273.PubMed Li C, Hu Y, Mayr M, Xu Q: Cyclic strain stress-induced mitogen-activated protein kinase (MAPK) phosphatase 1 expression in vascular smooth muscle cells is regulated by Ras/Rac-MAPK pathways. J Biol Chem. 1999, 274: 25273-25280. 10.1074/jbc.274.36.25273.PubMed
7.
go back to reference Hu Y, Cheng L, Hochleitner BW, Xu Q: Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb. 1997, 17: 2808-2816. Hu Y, Cheng L, Hochleitner BW, Xu Q: Activation of mitogen-activated protein kinases (ERK/JNK) and AP-1 transcription factor in rat carotid arteries after balloon injury. Arterioscler Thromb. 1997, 17: 2808-2816.
8.
go back to reference Nagel T, Resnick N, Dewey CF, Gimbrone MA: Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler Thromb. 1999, 19: 1825-1834. Nagel T, Resnick N, Dewey CF, Gimbrone MA: Vascular endothelial cells respond to spatial gradients in fluid shear stress by enhanced activation of transcription factors. Arterioscler Thromb. 1999, 19: 1825-1834.
9.
go back to reference Hishikawa K, Oemar BS, Yang Z, Luscher TF: Pulsatile stretch stimulates superoxide production and activates nuclear factor-κB in human coronary smooth muscle. Circ Res. 1997, 81: 797-803.PubMed Hishikawa K, Oemar BS, Yang Z, Luscher TF: Pulsatile stretch stimulates superoxide production and activates nuclear factor-κB in human coronary smooth muscle. Circ Res. 1997, 81: 797-803.PubMed
10.
go back to reference Hochleitner BW, Hochleitner EO, Obrist P, Eberl T, Amberger A, Xu Q, Margreiter R, Wick G: Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arterioscler Thromb. 2000, 20: 617-623. Hochleitner BW, Hochleitner EO, Obrist P, Eberl T, Amberger A, Xu Q, Margreiter R, Wick G: Fluid shear stress induces heat shock protein 60 expression in endothelial cells in vitro and in vivo. Arterioscler Thromb. 2000, 20: 617-623.
11.
go back to reference Schett G, Redlich R, Xu Q, Bitzan P, Groger M, Tohidast-Akrad M, Kiener H, Smolen J, Steiner G: Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. J Clin Invest. 1998, 102: 302-312.PubMedPubMedCentral Schett G, Redlich R, Xu Q, Bitzan P, Groger M, Tohidast-Akrad M, Kiener H, Smolen J, Steiner G: Enhanced expression of heat shock protein 70 (hsp70) and heat shock factor 1 (HSF1) activation in rheumatoid arthritis synovial tissue. J Clin Invest. 1998, 102: 302-312.PubMedPubMedCentral
12.
go back to reference Vance BA, Kowalski CG, Brinckerhoff CE: Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin. J Cell Biol. 1989, 108: 2037-2043.PubMed Vance BA, Kowalski CG, Brinckerhoff CE: Heat shock of rabbit synovial fibroblasts increases expression of mRNAs for two metalloproteinases, collagenase and stromelysin. J Cell Biol. 1989, 108: 2037-2043.PubMed
13.
go back to reference Van Eden W, Young DB: Stress Proteins in Medicine. New York: Marcel Dekker, Inc;. 1996 Van Eden W, Young DB: Stress Proteins in Medicine. New York: Marcel Dekker, Inc;. 1996
14.
go back to reference Schlesinger MJ: Heat shock proteins. J Biol Chem. 1990, 265: 12111-12114.PubMed Schlesinger MJ: Heat shock proteins. J Biol Chem. 1990, 265: 12111-12114.PubMed
15.
go back to reference Lis J, Wu C: Protein trafficking on the heat shock promotor. Cell. 1993, 74: 1-4.PubMed Lis J, Wu C: Protein trafficking on the heat shock promotor. Cell. 1993, 74: 1-4.PubMed
16.
go back to reference Morimoto RI, Tissieres A, Georgopoulous C: The stress response, function of the proteins, and perspectives. In Stress Proteins in Biology and Medicine. Edited by Morimoto RI. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;. 1990 Morimoto RI, Tissieres A, Georgopoulous C: The stress response, function of the proteins, and perspectives. In Stress Proteins in Biology and Medicine. Edited by Morimoto RI. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory;. 1990
17.
go back to reference Xu Q, Fawcett TW, Udelsmann R, Holbrook NJ: Activation of heat shock transcription factor 1 in rat aorta in response to high blood pressure. Hypertension. 1996, 28: 53-57.PubMed Xu Q, Fawcett TW, Udelsmann R, Holbrook NJ: Activation of heat shock transcription factor 1 in rat aorta in response to high blood pressure. Hypertension. 1996, 28: 53-57.PubMed
18.
go back to reference Liu H, Lightfoot R, Stevens JL: Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols. J Biol Chem. 1996, 271: 4805-4812. 10.1074/jbc.271.9.4805.PubMed Liu H, Lightfoot R, Stevens JL: Activation of heat shock factor by alkylating agents is triggered by glutathione depletion and oxidation of protein thiols. J Biol Chem. 1996, 271: 4805-4812. 10.1074/jbc.271.9.4805.PubMed
19.
go back to reference Strandell E, Buschard K, Saldeen J, Welsh N: Interleukin-1 beta induces the expression of hsp70, heme oxygenase and Mn-SOD in FACS-purified rat island beta-cells, but not in alpha-cells. Immunol Lett. 1995, 48: 145-148. 10.1016/0165-2478(95)02459-X.PubMed Strandell E, Buschard K, Saldeen J, Welsh N: Interleukin-1 beta induces the expression of hsp70, heme oxygenase and Mn-SOD in FACS-purified rat island beta-cells, but not in alpha-cells. Immunol Lett. 1995, 48: 145-148. 10.1016/0165-2478(95)02459-X.PubMed
20.
go back to reference Cohen IR, Young DB: Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today. 1991, 12: 105-110.PubMed Cohen IR, Young DB: Autoimmunity, microbial immunity and the immunological homunculus. Immunol Today. 1991, 12: 105-110.PubMed
21.
go back to reference Celis L, Vandvyver C, Geusens P, Dequeker J, Raus J, Zhang J: Clonal expansion of mycobacterial heat shock protein-reactive T lymphocytes in synovial fluid and and blood of rheumatoid arthritis patients. Arthritis Rheum. 1997, 40: 510-519.PubMed Celis L, Vandvyver C, Geusens P, Dequeker J, Raus J, Zhang J: Clonal expansion of mycobacterial heat shock protein-reactive T lymphocytes in synovial fluid and and blood of rheumatoid arthritis patients. Arthritis Rheum. 1997, 40: 510-519.PubMed
22.
go back to reference de Graeff Meeder ER, van der Zee R, Rijkers GT, Schuurman HJ, Kuis W, Bijlsma JW, Zegers BJ, van-Eden W: Recognition of human 60kD heat shock protein by mononuclear cells from patients with juvenile chronic polyarthritis. Lancet. 1991, 337: 1368-1372. 10.1016/0140-6736(91)93057-G.PubMed de Graeff Meeder ER, van der Zee R, Rijkers GT, Schuurman HJ, Kuis W, Bijlsma JW, Zegers BJ, van-Eden W: Recognition of human 60kD heat shock protein by mononuclear cells from patients with juvenile chronic polyarthritis. Lancet. 1991, 337: 1368-1372. 10.1016/0140-6736(91)93057-G.PubMed
23.
go back to reference Sharif M, Worall JG, Singh B, Gupta RS, Lydyard PM, Lambert C, McCulloch J, Rook GA: The development of monoclonal antibodies to the human mitochondrial 60-kd heta shock protein, and their use in studying the expression of the protein in rheumatoid arthritis. Arthritis Rheum. 1992, 35: 1427-1433.PubMed Sharif M, Worall JG, Singh B, Gupta RS, Lydyard PM, Lambert C, McCulloch J, Rook GA: The development of monoclonal antibodies to the human mitochondrial 60-kd heta shock protein, and their use in studying the expression of the protein in rheumatoid arthritis. Arthritis Rheum. 1992, 35: 1427-1433.PubMed
24.
go back to reference Evans DJ, Norton P, Ivanji J: Distribution in tissue sections of the human groEL-stress protein homologue. APMIS. 1990, 98: 437-441.PubMed Evans DJ, Norton P, Ivanji J: Distribution in tissue sections of the human groEL-stress protein homologue. APMIS. 1990, 98: 437-441.PubMed
25.
go back to reference Karlsson Parra A, Soderstrom K, Ferm M, Ivanyi J, Kiessling R, Klareskog L: Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients. Scand J Immunol. 1990, 31: 283-288.PubMed Karlsson Parra A, Soderstrom K, Ferm M, Ivanyi J, Kiessling R, Klareskog L: Presence of human 65 kD heat shock protein (hsp) in inflamed joints and subcutaneous nodules of RA patients. Scand J Immunol. 1990, 31: 283-288.PubMed
26.
go back to reference Sato H, Miyata M, Kasukawa R: Expression of heat shock protein on lymphocytes in peripheral blood and synovial fluid from patients with rheumatoid arthritis. J Rheum. 1996, 23: 2027-2032.PubMed Sato H, Miyata M, Kasukawa R: Expression of heat shock protein on lymphocytes in peripheral blood and synovial fluid from patients with rheumatoid arthritis. J Rheum. 1996, 23: 2027-2032.PubMed
27.
go back to reference Miyata M, Sato H, Sato H, Sato Y, Kodama E, Kasukawa R: Significance of endogenous heat shock protein in adjuvant arthritis. J Rheum. 1999, 26: 2210-2214.PubMed Miyata M, Sato H, Sato H, Sato Y, Kodama E, Kasukawa R: Significance of endogenous heat shock protein in adjuvant arthritis. J Rheum. 1999, 26: 2210-2214.PubMed
28.
go back to reference Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Wick G: Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 1995, 96: 2569-2577.PubMedPubMedCentral Schett G, Xu Q, Amberger A, Van der Zee R, Recheis H, Wick G: Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity. J Clin Invest. 1995, 96: 2569-2577.PubMedPubMedCentral
29.
go back to reference Soltys BJ, Gupta RS: Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol Int. 1997, 21: 315-320. 10.1006/cbir.1997.0144.PubMed Soltys BJ, Gupta RS: Cell surface localization of the 60 kDa heat shock chaperonin protein (hsp60) in mammalian cells. Cell Biol Int. 1997, 21: 315-320. 10.1006/cbir.1997.0144.PubMed
30.
go back to reference Hogervorst EJM, Wagenaar JPA, Wagenaar CJP, Boog R, van der Zee R, van Emden JDA, van Eden W: Adjuvant arthritis and immunity to the mycobacterial heat 65-kD heat shock protein. Int Immunol. 1992, 4: 719-727.PubMed Hogervorst EJM, Wagenaar JPA, Wagenaar CJP, Boog R, van der Zee R, van Emden JDA, van Eden W: Adjuvant arthritis and immunity to the mycobacterial heat 65-kD heat shock protein. Int Immunol. 1992, 4: 719-727.PubMed
31.
go back to reference Prakken AB, van Eden W, Rijkers GT, Kuis W, Toebes EA, de-Graeff-Meeder ER, van-der-Zee R, Zegers BJ: Autoreactivity to human heat shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. 1996, 39: 1826-1832.PubMed Prakken AB, van Eden W, Rijkers GT, Kuis W, Toebes EA, de-Graeff-Meeder ER, van-der-Zee R, Zegers BJ: Autoreactivity to human heat shock protein 60 predicts disease remission in oligoarticular juvenile rheumatoid arthritis. Arthritis Rheum. 1996, 39: 1826-1832.PubMed
32.
go back to reference de Graeff Meeder ER, van Eden W, Rijkers GT, Prakken AB, Kuis W, Voorhorst-Ogink MM, van-der-Zee R: Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favourable course of arthritis. J Clin Invest. 1995, 95: 934-940.PubMedPubMedCentral de Graeff Meeder ER, van Eden W, Rijkers GT, Prakken AB, Kuis W, Voorhorst-Ogink MM, van-der-Zee R: Juvenile chronic arthritis: T cell reactivity to human HSP60 in patients with a favourable course of arthritis. J Clin Invest. 1995, 95: 934-940.PubMedPubMedCentral
33.
go back to reference Mosser DD, Caron A, Bourget L, Denis-Larose C, Massie B: Role of human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol. 1997, 17: 5317-5322.PubMedPubMedCentral Mosser DD, Caron A, Bourget L, Denis-Larose C, Massie B: Role of human heat shock protein hsp70 in protection against stress-induced apoptosis. Mol Cell Biol. 1997, 17: 5317-5322.PubMedPubMedCentral
34.
go back to reference Schett G, Steiner CW, Gröger M, Winkler S, Graninger W, Smolen J, Xu Q, Steiner G: Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70. FASEB J. 1999, 13: 833-842.PubMed Schett G, Steiner CW, Gröger M, Winkler S, Graninger W, Smolen J, Xu Q, Steiner G: Activation of Fas inhibits heat-induced activation of HSF1 and up-regulation of hsp70. FASEB J. 1999, 13: 833-842.PubMed
35.
go back to reference Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K: Localization of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 442-449.PubMedPubMedCentral Sugiyama M, Tsukazaki T, Yonekura A, Matsuzaki S, Yamashita S, Iwasaki K: Localization of apoptosis and expression of apoptosis related proteins in the synovium of patients with rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 442-449.PubMedPubMedCentral
36.
go back to reference Asahara H, Hasunuma T, Kobata T, Inoue H, Muller-Ladner U, Gay S, Sumida T, Nishioka K: In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium. J Rheumatol. 1997, 24: 430-435.PubMed Asahara H, Hasunuma T, Kobata T, Inoue H, Muller-Ladner U, Gay S, Sumida T, Nishioka K: In situ expression of protooncogenes and Fas/Fas ligand in rheumatoid arthritis synovium. J Rheumatol. 1997, 24: 430-435.PubMed
37.
go back to reference Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Muller-Ladner U, Gay RE, Gay S: Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 599-607. 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO;2-T.PubMed Franz JK, Pap T, Hummel KM, Nawrath M, Aicher WK, Shigeyama Y, Muller-Ladner U, Gay RE, Gay S: Expression of sentrin, a novel antiapoptotic molecule, at sites of synovial invasion in rheumatoid arthritis. Arthritis Rheum. 2000, 43: 599-607. 10.1002/1529-0131(200003)43:3<599::AID-ANR17>3.0.CO;2-T.PubMed
38.
go back to reference Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994, 78: 1027-1037.PubMed Rouse J, Cohen P, Trigon S, Morange M, Alonso-Llamazares A, Zamanillo D, Hunt T, Nebreda AR: A novel kinase cascade triggered by stress and heat shock that stimulates MAPKAP kinase-2 and phosphorylation of the small heat shock proteins. Cell. 1994, 78: 1027-1037.PubMed
39.
go back to reference Zvaifler NJ: Editorial. Rheumatoid arthritis: the multiple pathways to chronic synovitis. Lab Invest. 1995, 73: 307-310.PubMed Zvaifler NJ: Editorial. Rheumatoid arthritis: the multiple pathways to chronic synovitis. Lab Invest. 1995, 73: 307-310.PubMed
40.
go back to reference Firestein GS, Manning AM: Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 1999, 42: 609-621. 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I.PubMed Firestein GS, Manning AM: Signal transduction and transcription factors in rheumatic disease. Arthritis Rheum. 1999, 42: 609-621. 10.1002/1529-0131(199904)42:4<609::AID-ANR3>3.0.CO;2-I.PubMed
41.
go back to reference Smolen JS, Tohidast-Akrad M, Gal A, Kunaver M, Eberl G, Zenz P, Falus A, Steiner G: The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol. 1996, 25: 1-4.PubMed Smolen JS, Tohidast-Akrad M, Gal A, Kunaver M, Eberl G, Zenz P, Falus A, Steiner G: The role of T-lymphocytes and cytokines in rheumatoid arthritis. Scand J Rheumatol. 1996, 25: 1-4.PubMed
42.
go back to reference Brennan FM, Maini RN, Feldmann M: Role of pro-inflammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol. 1998, 20: 133-147.PubMed Brennan FM, Maini RN, Feldmann M: Role of pro-inflammatory cytokines in rheumatoid arthritis. Springer Semin Immunopathol. 1998, 20: 133-147.PubMed
43.
go back to reference Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and the cartilage pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991, 34: 1125-1132.PubMed Chu CQ, Field M, Feldmann M, Maini RN: Localization of tumor necrosis factor α in synovial tissues and the cartilage pannus junction in patients with rheumatoid arthritis. Arthritis Rheum. 1991, 34: 1125-1132.PubMed
44.
go back to reference Farahat MN, Yanni G, Poston R, Panayi GS: Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 1993, 52: 870-875.PubMedPubMedCentral Farahat MN, Yanni G, Poston R, Panayi GS: Cytokine expression in synovial membranes of patients with rheumatoid arthritis and osteoarthritis. Ann Rheum Dis. 1993, 52: 870-875.PubMedPubMedCentral
45.
go back to reference Brennan FM, Gibbons DL, Mitchell T, Cope AP, Maini RN, Feldmann M: Enhanced expression of TNF receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints. Eur J Immunol. 1992, 22: 1907-1912.PubMed Brennan FM, Gibbons DL, Mitchell T, Cope AP, Maini RN, Feldmann M: Enhanced expression of TNF receptor mRNA and protein in mononuclear cells isolated from rheumatoid arthritis synovial joints. Eur J Immunol. 1992, 22: 1907-1912.PubMed
46.
go back to reference Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS: Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology. 1999, 38: 202-213. 10.1093/rheumatology/38.3.202.PubMed Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS: Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology. 1999, 38: 202-213. 10.1093/rheumatology/38.3.202.PubMed
47.
go back to reference Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomized double blind comparison of a chimaeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994, 344: 1105-1110. 10.1016/S0140-6736(94)90628-9.PubMed Elliott MJ, Maini RN, Feldmann M, Kalden JR, Antoni C, Smolen JS, Leeb B, Breedveld FC, Macfarlane JD, Bijl H, Woody JN: Randomized double blind comparison of a chimaeric monoclonal antibody to tumor necrosis factor α (cA2) versus placebo in rheumatoid arthritis. Lancet. 1994, 344: 1105-1110. 10.1016/S0140-6736(94)90628-9.PubMed
48.
go back to reference Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 1995, 38: 1151-1160. Arend WP, Dayer JM: Inhibition of the production and effects of interleukin-1 and tumor necrosis factor α in rheumatoid arthritis. Arthritis Rheum. 1995, 38: 1151-1160.
49.
go back to reference Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D: Tumor necrosis factor (cachectin) interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med. 1986, 163: 1363-PubMed Nawroth PP, Bank I, Handley D, Cassimeris J, Chess L, Stern D: Tumor necrosis factor (cachectin) interacts with endothelial cell receptors to induce release of interleukin 1. J Exp Med. 1986, 163: 1363-PubMed
50.
go back to reference Brennan FM, Jackson A, Chantry D, Maini R, Feldmann M: Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet. 1989, 2: 244-247. 10.1016/S0140-6736(89)90430-3.PubMed Brennan FM, Jackson A, Chantry D, Maini R, Feldmann M: Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis. Lancet. 1989, 2: 244-247. 10.1016/S0140-6736(89)90430-3.PubMed
51.
go back to reference Dayer JM, de Rochemonteix B, Burrus B, Denczuk S, Dinarello CA: Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest. 1986, 77: 645-648.PubMedPubMedCentral Dayer JM, de Rochemonteix B, Burrus B, Denczuk S, Dinarello CA: Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells. J Clin Invest. 1986, 77: 645-648.PubMedPubMedCentral
52.
go back to reference Saklatvala J: Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 1986, 322: 547-549.PubMed Saklatvala J: Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature. 1986, 322: 547-549.PubMed
53.
go back to reference Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996, 380: 75-79. 10.1038/380075a0.PubMed Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz-Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature. 1996, 380: 75-79. 10.1038/380075a0.PubMed
54.
go back to reference Mercurio F, Manning AM: NF-κB as a primary regulator of the stress response. Oncogene. 1999, 18: 6163-6171. 10.1038/sj/onc/1203174.PubMed Mercurio F, Manning AM: NF-κB as a primary regulator of the stress response. Oncogene. 1999, 18: 6163-6171. 10.1038/sj/onc/1203174.PubMed
55.
go back to reference Rath PC, Aggarwal BB: TNF-induced signaling in apoptosis. J Clin Immunol. 1999, 19: 350-364. 10.1023/A:1020546615229.PubMed Rath PC, Aggarwal BB: TNF-induced signaling in apoptosis. J Clin Immunol. 1999, 19: 350-364. 10.1023/A:1020546615229.PubMed
56.
go back to reference Kyriakis JM, Avruch J: Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem. 1996, 271: 24313-24316. 10.1074/jbc.271.40.24313.PubMed Kyriakis JM, Avruch J: Sounding the alarm: protein kinase cascades activated by stress and inflammation. J Biol Chem. 1996, 271: 24313-24316. 10.1074/jbc.271.40.24313.PubMed
57.
go back to reference Canman CE, Kastan MB: Three pathways to stress relief. Nature. 1996, 384: 213-214. 10.1038/384213a0.PubMed Canman CE, Kastan MB: Three pathways to stress relief. Nature. 1996, 384: 213-214. 10.1038/384213a0.PubMed
58.
go back to reference Schett G, Tohidast-Akrad M, Smolen JS, Redlich K, Steiner G: Differential induction, localization and regulation of stress-activated protein kinases, ERK-, JNK and p38, activation in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2000, 43(suppl): 186- Schett G, Tohidast-Akrad M, Smolen JS, Redlich K, Steiner G: Differential induction, localization and regulation of stress-activated protein kinases, ERK-, JNK and p38, activation in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2000, 43(suppl): 186-
59.
go back to reference Schett G, Tohidast-Akrad M, Smolen JS, Jahn Schmid B, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G: Activation, differential localization and regulation of stress-activated protein kinases, ERK-, JNK and p38 in synovial tissue and cells of rheumatoid arthritis. Arthritis Rheum. 2000, 43: 2501-2512. 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K.PubMed Schett G, Tohidast-Akrad M, Smolen JS, Jahn Schmid B, Steiner CW, Bitzan P, Zenz P, Redlich K, Xu Q, Steiner G: Activation, differential localization and regulation of stress-activated protein kinases, ERK-, JNK and p38 in synovial tissue and cells of rheumatoid arthritis. Arthritis Rheum. 2000, 43: 2501-2512. 10.1002/1529-0131(200011)43:11<2501::AID-ANR18>3.0.CO;2-K.PubMed
60.
go back to reference Rosseau S, Houle F, Landry J, Huot J: p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 1997, 15: 2169-2177. 10.1038/sj/onc/1201380. Rosseau S, Houle F, Landry J, Huot J: p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene. 1997, 15: 2169-2177. 10.1038/sj/onc/1201380.
61.
go back to reference Read MA, Whitley MZ, Gupta S, Pierce JW, Best J, Davis RJ, Collins T: Tumor necrosis factor α- induced E- selectin expression is activated by the nuclear factor-κB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem. 1997, 272: 2753-2761. 10.1074/jbc.272.29.18498.PubMed Read MA, Whitley MZ, Gupta S, Pierce JW, Best J, Davis RJ, Collins T: Tumor necrosis factor α- induced E- selectin expression is activated by the nuclear factor-κB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways. J Biol Chem. 1997, 272: 2753-2761. 10.1074/jbc.272.29.18498.PubMed
62.
go back to reference Pietersma A, Tilly BC, Gaestel M, de Jong N, Lee JC, Koster JF, Sluiter W: p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun. 1997, 230: 44-48. 10.1006/bbrc.1996.5886.PubMed Pietersma A, Tilly BC, Gaestel M, de Jong N, Lee JC, Koster JF, Sluiter W: p38 mitogen activated protein kinase regulates endothelial VCAM-1 expression at the post-transcriptional level. Biochem Biophys Res Commun. 1997, 230: 44-48. 10.1006/bbrc.1996.5886.PubMed
63.
go back to reference Goebeler M, Kilian K, Gillitzer R, Kunz M, Yoshimura T, Brocker EB, Rapp UR, Ludwig S: The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-α-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood. 1999, 93: 857-865.PubMed Goebeler M, Kilian K, Gillitzer R, Kunz M, Yoshimura T, Brocker EB, Rapp UR, Ludwig S: The MKK6/p38 stress kinase cascade is critical for tumor necrosis factor-α-induced expression of monocyte-chemoattractant protein-1 in endothelial cells. Blood. 1999, 93: 857-865.PubMed
64.
go back to reference Tanaka K, Oda N, Iwasaka C, Abe M, Sato Y: Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol. 1998, 176: 235-244. 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P.PubMed Tanaka K, Oda N, Iwasaka C, Abe M, Sato Y: Induction of Ets-1 in endothelial cells during reendothelialization after denuding injury. J Cell Physiol. 1998, 176: 235-244. 10.1002/(SICI)1097-4652(199808)176:2<235::AID-JCP2>3.0.CO;2-P.PubMed
65.
go back to reference Redlich K, Kiener HP, Schett G, Tohidast-Akrad M, Radda I, Stummvoll GH, Bitzan P, Smolen JS, Steiner G: The transcription factor ETS-1 is overexpressed in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2001, Redlich K, Kiener HP, Schett G, Tohidast-Akrad M, Radda I, Stummvoll GH, Bitzan P, Smolen JS, Steiner G: The transcription factor ETS-1 is overexpressed in rheumatoid arthritis synovial tissue. Arthritis Rheum. 2001,
66.
go back to reference Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW, Plevin R: Stress-activated protein kinases: activation, regulation and function. Cell Signal. 1997, 9: 403-410. 10.1016/S0898-6568(97)00042-9.PubMed Paul A, Wilson S, Belham CM, Robinson CJ, Scott PH, Gould GW, Plevin R: Stress-activated protein kinases: activation, regulation and function. Cell Signal. 1997, 9: 403-410. 10.1016/S0898-6568(97)00042-9.PubMed
67.
go back to reference Lee JC, Laydon JT, McConnell PC, Gallagher JF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW: A protein kinase involved in the regulation of inflammatory cytokine synthesis. Nature. 1994, 372: 739-746. 10.1038/372739a0.PubMed Lee JC, Laydon JT, McConnell PC, Gallagher JF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW: A protein kinase involved in the regulation of inflammatory cytokine synthesis. Nature. 1994, 372: 739-746. 10.1038/372739a0.PubMed
68.
go back to reference Beyaert R, Cuenda C, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W: The p38/RK protein mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996, 15: 1914-1923.PubMedPubMedCentral Beyaert R, Cuenda C, Vanden Berghe W, Plaisance S, Lee JC, Haegeman G, Cohen P, Fiers W: The p38/RK protein mitogen-activated protein kinase pathway regulates interleukin-6 synthesis response to tumor necrosis factor. EMBO J. 1996, 15: 1914-1923.PubMedPubMedCentral
69.
go back to reference Krause A, Holtmann H, Eickemeier S, Winzen R, Szamel M, Resch K, Saklatvala J, Kracht M: Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. J Biol Chem. 1998, 273: 23681-23689. 10.1074/jbc.273.37.23681.PubMed Krause A, Holtmann H, Eickemeier S, Winzen R, Szamel M, Resch K, Saklatvala J, Kracht M: Stress-activated protein kinase/Jun N-terminal kinase is required for interleukin (IL)-1-induced IL-6 and IL-8 gene expression in the human epidermal carcinoma cell line KB. J Biol Chem. 1998, 273: 23681-23689. 10.1074/jbc.273.37.23681.PubMed
70.
go back to reference Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM: Stress-activated protein kinases in cardiovascular disease. Circ Res. 1996, 78: 947-953.PubMed Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM: Stress-activated protein kinases in cardiovascular disease. Circ Res. 1996, 78: 947-953.PubMed
71.
go back to reference Dong C, Yang DD, Tournier C, Whitmarsh AJ, Xu J, Davis RJ, Flavell RA: JNK is required for effector T-cell function but not for T-cell activation. Nature. 2000, 405: 91-94. 10.1016/S0014-5793(97)00162-2.PubMed Dong C, Yang DD, Tournier C, Whitmarsh AJ, Xu J, Davis RJ, Flavell RA: JNK is required for effector T-cell function but not for T-cell activation. Nature. 2000, 405: 91-94. 10.1016/S0014-5793(97)00162-2.PubMed
72.
go back to reference Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, Wu W, Fahmy B, Olini GC, Davis JE, Pellegrino-Gensey JL, Wachter MP, Siekierka JJ: RWJ 67657 a potent, orally active inhibitor of p38-mitogen-activated protein kinase. J Pharm Exp Ther. 1999, 291: 680-687. Wadsworth SA, Cavender DE, Beers SA, Lalan P, Schafer PH, Malloy EA, Wu W, Fahmy B, Olini GC, Davis JE, Pellegrino-Gensey JL, Wachter MP, Siekierka JJ: RWJ 67657 a potent, orally active inhibitor of p38-mitogen-activated protein kinase. J Pharm Exp Ther. 1999, 291: 680-687.
73.
go back to reference Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van-der-Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL: Expression of the thioredoxin-thioredoxin-reductase system in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42: 2430-2439. 10.1002/1529-0131(199911)42:11<2430::AID-ANR22>3.0.CO;2-6.PubMed Maurice MM, Nakamura H, Gringhuis S, Okamoto T, Yoshida S, Kullmann F, Lechner S, van-der-Voort EA, Leow A, Versendaal J, Muller-Ladner U, Yodoi J, Tak PP, Breedveld FC, Verweij CL: Expression of the thioredoxin-thioredoxin-reductase system in inflamed joints of patients with rheumatoid arthritis. Arthritis Rheum. 1999, 42: 2430-2439. 10.1002/1529-0131(199911)42:11<2430::AID-ANR22>3.0.CO;2-6.PubMed
74.
go back to reference Yoshida S, Katoh T, Tetsuka T, Uno K, Matsui N, Okamoto T: Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-α-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. J Immunol. 1999, 163: 351-358.PubMed Yoshida S, Katoh T, Tetsuka T, Uno K, Matsui N, Okamoto T: Involvement of thioredoxin in rheumatoid arthritis: its costimulatory roles in the TNF-α-induced production of IL-6 and IL-8 from cultured synovial fibroblasts. J Immunol. 1999, 163: 351-358.PubMed
75.
go back to reference Backman JT, Siegle I, Fritz P: Immunohistochemical localization of metallothionein in synovial tissue of patients with chronic inflammatory and degenerative joint disease. Virchows Arch. 1998, 433: 153-160. 10.1007/s004280050230.PubMed Backman JT, Siegle I, Fritz P: Immunohistochemical localization of metallothionein in synovial tissue of patients with chronic inflammatory and degenerative joint disease. Virchows Arch. 1998, 433: 153-160. 10.1007/s004280050230.PubMed
76.
go back to reference Mulherin DM, Thurnham DI, Situnayake RD: Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 837-840.PubMedPubMedCentral Mulherin DM, Thurnham DI, Situnayake RD: Glutathione reductase activity, riboflavin status, and disease activity in rheumatoid arthritis. Ann Rheum Dis. 1996, 55: 837-840.PubMedPubMedCentral
77.
go back to reference Tak PP, Zvaifler NJ, Green DR, Firestein GS: Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today. 2000, 21: 78-82. 10.1016/S0167-5699(99)01552-2.PubMed Tak PP, Zvaifler NJ, Green DR, Firestein GS: Rheumatoid arthritis and p53: how oxidative stress might alter the course of inflammatory diseases. Immunol Today. 2000, 21: 78-82. 10.1016/S0167-5699(99)01552-2.PubMed
78.
go back to reference Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ: Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol. 1996, 149: 143-151. Firestein GS, Nguyen K, Aupperle KR, Yeo M, Boyle DL, Zvaifler NJ: Apoptosis in rheumatoid arthritis: p53 overexpression in rheumatoid arthritis synovium. Am J Pathol. 1996, 149: 143-151.
79.
go back to reference Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA. 1997, 94: 10895-10900. 10.1073/pnas.94.20.10895.PubMed Firestein GS, Echeverri F, Yeo M, Zvaifler NJ, Green DR: Somatic mutations in the p53 tumor suppressor gene in rheumatoid arthritis synovium. Proc Natl Acad Sci USA. 1997, 94: 10895-10900. 10.1073/pnas.94.20.10895.PubMed
Metadata
Title
The stressed synovium
Authors
Georg Schett
Makiyeh Tohidast-Akrad
Günter Steiner
Josef Smolen
Publication date
01-01-2001
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 2/2001
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar144

Other articles of this Issue 2/2001

Arthritis Research & Therapy 2/2001 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine